Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 45

1.

Association of HLA-B*5801 allele and allopurinol-induced Stevens Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Somkrua R, Eickman EE, Saokaew S, Lohitnavy M, Chaiyakunapruk N.

BMC Med Genet. 2011 Sep 9;12:118. doi: 10.1186/1471-2350-12-118. Review.

2.

Relationship between the HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis.

Tangamornsuksan W, Chaiyakunapruk N, Somkrua R, Lohitnavy M, Tassaneeyakul W.

JAMA Dermatol. 2013 Sep;149(9):1025-32. doi: 10.1001/jamadermatol.2013.4114. Review.

PMID:
23884208
3.

Toxic epidermal necrolysis and Stevens-Johnson syndrome.

Harr T, French LE.

Orphanet J Rare Dis. 2010 Dec 16;5:39. doi: 10.1186/1750-1172-5-39. Review.

4.

Genetic markers and danger signals in stevens-johnson syndrome and toxic epidermal necrolysis.

Chung WH, Hung SI.

Allergol Int. 2010 Dec;59(4):325-32. doi: 10.2332/allergolint.10-RAI-0261. Epub 2010 Oct 25. Review.

5.

Human leukocyte antigens and drug hypersensitivity.

Chung WH, Hung SI, Chen YT.

Curr Opin Allergy Clin Immunol. 2007 Aug;7(4):317-23. Review.

PMID:
17620823
6.

Pharmacogenetics of cutaneous adverse drug reactions.

Aihara M.

J Dermatol. 2011 Mar;38(3):246-54. doi: 10.1111/j.1346-8138.2010.01196.x. Review.

PMID:
21342226
7.

Recent advances in the genetics and immunology of Stevens-Johnson syndrome and toxic epidermal necrosis.

Chung WH, Hung SI.

J Dermatol Sci. 2012 Jun;66(3):190-6. doi: 10.1016/j.jdermsci.2012.04.002. Epub 2012 Apr 11. Review.

PMID:
22541332
8.

[Exploratory study on biomarkers associated with severe cutaneous adverse reactions].

Kaniwa N.

Yakugaku Zasshi. 2011 Feb;131(2):255-61. Review. Japanese.

9.

Pharmacogenetics of toxic epidermal necrolysis.

Lee MT, Hung SI, Wei CY, Chen YT.

Expert Opin Pharmacother. 2010 Sep;11(13):2153-62. doi: 10.1517/14656566.2010.495120. Review.

PMID:
20536296
10.

HLA-B*5801: utility and cost-effectiveness in the Asia-Pacific Region.

Yeo SI.

Int J Rheum Dis. 2013 Jun;16(3):254-7. doi: 10.1111/1756-185X.12050. Epub 2013 Apr 26. Review.

PMID:
23981744
11.

[Exploratory studies on genetic biomarkers related to serious drug adverse reactions].

Kaniwa N, Hasegawa R.

Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku. 2009;(127):1-14. Review. Japanese.

PMID:
20306701
12.

[Stevens-Johnson syndrome and toxic epidermal necrolysis--updates and innovations].

Halevy S.

Harefuah. 2010 Mar;149(3):186-90, 193. Review. Hebrew.

PMID:
20684173
13.

Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with lupus erythematosus: a descriptive study of 17 cases from a national registry and review of the literature.

Ziemer M, Kardaun SH, Liss Y, Mockenhaupt M.

Br J Dermatol. 2012 Mar;166(3):575-600. doi: 10.1111/j.1365-2133.2011.10705.x. Review.

PMID:
22014091
14.

Stevens-Johnson syndrome induced by acetazolamide.

Her Y, Kil MS, Park JH, Kim CW, Kim SS.

J Dermatol. 2011 Mar;38(3):272-5. doi: 10.1111/j.1346-8138.2010.00921.x. Epub 2010 Dec 13. Review.

PMID:
21342230
15.

Genetic predisposition of life-threatening antiepileptic-induced skin reactions.

Chung WH, Hung SI, Chen YT.

Expert Opin Drug Saf. 2010 Jan;9(1):15-21. doi: 10.1517/14740330903427969. Review.

PMID:
20001755
16.

Pharmacogenetic screening of carbamazepine-induced severe cutaneous allergic reactions.

Locharernkul C, Shotelersuk V, Hirankarn N.

J Clin Neurosci. 2011 Oct;18(10):1289-94. doi: 10.1016/j.jocn.2010.12.054. Epub 2011 Jul 28. Review.

PMID:
21802305
17.

HLA genotype and carbamazepine-induced cutaneous adverse drug reactions: a systematic review.

Yip VL, Marson AG, Jorgensen AL, Pirmohamed M, Alfirevic A.

Clin Pharmacol Ther. 2012 Dec;92(6):757-65. doi: 10.1038/clpt.2012.189. Epub 2012 Nov 7. Review.

PMID:
23132554
18.

A systematic review of treatment of drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in children.

Del Pozzo-Magana BR, Lazo-Langner A, Carleton B, Castro-Pastrana LI, Rieder MJ.

J Popul Ther Clin Pharmacol. 2011;18:e121-33. Epub 2011 Mar 21. Review.

19.

Genotyping for severe drug hypersensitivity.

Karlin E, Phillips E.

Curr Allergy Asthma Rep. 2014 Mar;14(3):418. doi: 10.1007/s11882-013-0418-0. Review.

20.

Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.

Mittmann N, Chan B, Knowles S, Cosentino L, Shear N.

Am J Clin Dermatol. 2006;7(6):359-68. Review.

PMID:
17173470
Items per page

Supplemental Content

Write to the Help Desk